Padcev
(Enfortumab vedotin)
(30)
(one)
(Bottle)
Padcev (enfortumab vedotin) 30 mg
In Stock
Summary
Enfortumab vedotin is an antibody-drug conjugate comprised of a fully human monoclonal antibody and microtubule-disrupting chemotherapeutic agent used in the treatment of advanced or metastatic urothelial cancer.
-
Commercial name:Padcev
-
Сhemical name:Enfortumab vedotin
-
Dosage:30
-
Quantity:one
-
Release form:Bottle
No reviews yet